Boothbay Fund Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Boothbay Fund Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-250,000	Closed	-$7.19M	–	1509
2024 Q1	$7.19M	Buy	+250,000	New	+$7.52M	0.14%	129
2021 Q3	–	Sell	-13,700	Closed	-$1.27M	–	1886
2021 Q2	$1.27M	Buy	13,700 +12,771	+1,375%	+$1.09M	0.04%	582
2021 Q1	$8.24M	Buy	929 +464	+100%	+$46K	0.31%	48
2020 Q4	$4.34M	Buy	+465	New	+$37K	0.16%	112

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Boothbay Fund Management's ARKG Position: Q3 2023 in Review

Boothbay Fund Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 7,021 shares — an estimated $239K sold.

Boothbay Fund Management first reported a position in ARKG in Q3 2022 and held it in 4 quarters. The position peaked at $497K in Q3 2022. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

Boothbay Fund Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 7,021 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $239K.
Boothbay Fund Management first reported a position in ARK Genomic Revolution ETF in Q3 2022 and held it in 4 quarters.
Boothbay Fund Management's ARK Genomic Revolution ETF position peaked at $497K in Q3 2022.
286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.